首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of addiction medicine

缩写:J ADDICT MED

ISSN:1932-0620

e-ISSN:1935-3227

IF/分区:3.1/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1852条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Madeline B Benz,Michael D Stein,Camille Clifford et al. Madeline B Benz et al.
Despite a recent decline in overdose deaths, the United States continues to have the highest global overdose mortality rate. Polysubstance use-taking opioids along with other drugs-has been increasingly recognized as a key contributor to pr...
Sarah Kawasaki,Erik Lehman,Lan Kong et al. Sarah Kawasaki et al.
Objectives: This study evaluated ReSET-O, a mobile app derived from the previously studied, computer-based therapeutic education system (TES), delivering cognitive behavioral therapy (CBT) lessons plus contingency managem...
Payel Jhoom Roy,Nalingna Yuan,Yaming Li et al. Payel Jhoom Roy et al.
Objectives: In 2022, the FDA issued a drug safety communication based on case studies that transmucosal buprenorphine, a medication for opioid use disorder (MOUD), may contribute to dental disease. We sought to assess lon...
James R Langabeer,Andrea J Yatsco,Cohen A Sarah et al. James R Langabeer et al.
Objectives: Treatment for opioid use disorder (OUD) is constrained by financial and geographic barriers. Community-based approaches may help address these challenges, yet evidence regarding their sustained impact on treat...
Xavier Alexander Calicdan,Anika Kopczynski,Edwin Medina et al. Xavier Alexander Calicdan et al.
Objectives: Kratom ( Mitragyna speciosa ) is a psychoactive herbal product increasingly used for pain, anxiety, and opioid withdrawal. Although marketed as a natural dietary product, concerns have emerged regarding advers...
Mayu Koga,Simon Coulombe,Hideaki Tanaka et al. Mayu Koga et al.
Objectives: To examine trends and predictors of prescription drug substance use disorders (RxSUDs), highlighting risk and protective factors, with a particular focus on patient recovery capital (social factors known to pr...
Eloise Fourie,Megan T Mitchell,Paul Anaya et al. Eloise Fourie et al.
Background: Methadone remains the most utilized medication for opioid use disorder (MOUD) with significant mortality reduction. Methadone carries a black box warning for the prolongation of the corrected QT interval (QTc)...
Austin Daniel Solak,Jack Boynton,Jacob Riches et al. Austin Daniel Solak et al.
Objectives: While treatment guidelines for opioid use disorder (OUD) are well-established, specific guidance for people who use fentanyl remains limited. This systematic review is the first to examine effectiveness and sa...
Aaron D Fox,Sarah E Messmer,Benjamin T Hayes et al. Aaron D Fox et al.
Low-threshold buprenorphine treatment has been described as a general approach to office-based buprenorphine treatment that prioritizes access to care, flexibility, and patient-centeredness. Proposed principles have included same-day treatm...
Daniel M Bowen,Maryam Soltani Daniel M Bowen
Background: Urine toxicology is a cornerstone of monitoring abstinence in substance use disorder treatment, yet commonly cited detection windows are based on studies in healthy volunteers and do not account for metabolic ...